Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budgetary squeeze from fast-rising costs.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.

The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic.

For a Minnesota minor league baseball team known for a history of outlandish promotions, the idea of naming its longtime live pig mascot after the weight loss drug Ozempic made perfect sense.

Norway’s oil fund saw the largest annual return in its history in 2023 led by a strong performance by U.S. technology companies and the Danish weight loss drug manufacturer, Novo Nordisk.

The U.S. Food and Drug Administration says it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug widely used for weight loss.

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients.

A doctor talks about the effects of the wildly popular new drugs and what you should know before and after starting one.

Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.

The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.

Obesity is a major and growing problem around the world, but especially in the U.S. Researchers have long looked for medications that can help people lose weight, mostly with disappointing and, in some cases, dangerous results.

A diabetes drug being tested for weight loss is poised to further upend obesity care.

Ozempic, a medication for people dealing with Type 2 diabetes is in short supply around the nation right now, according to the FDA.